Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Erythropoietin Therapy for Children With Cerebral Palsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating erythropoietin therapy in children with cerebral palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Cerebral Palsy | Phase 2 | Status: COMPLETED